Brief: Pangen Biotech signs contract worth 194.7 mln won
05/07/2017 10:10
July 5(Reuters) - Pangen Biotech Inc 222110.KQ :
* Says it signed 194.7 million won contract with Yueqing
Kangnuo Biological Medicine Public Service Platform Co Ltd on
antibody cell line business
Source text in Korean: https://goo.gl/HtHF3H
Further company coverage: 222110.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724;
Reuters Messaging: Yinglan.Ma.reuters.com@reuters.net))